Masahiro Mitsuoka

Prognostic Value of Programmed Death Ligand 1 and Programmed Death 1 Expression in Thymic Carcinoma

Shintaro Yokoyama, Hiroaki Miyoshi, Kazutaka Nakashima et al. · Clinical Cancer Research · 2016 · 81 citations

Clinicopathologic and Prognostic Implications of Programmed Death Ligand 1 Expression in Thymoma

Shintaro Yokoyama, Hiroaki Miyoshi, Tatsuya Nishi et al. · The Annals of Thoracic Surgery · 2016 · 69 citations · Full text

Thyroid Disease, Immunology, Cell Death +8

Co-existence of positive MET FISH status with EGFR mutations signifies poor prognosis in lung adenocarcinoma patients

Aya Tanaka, Naoko Sueoka‐Aragane, Tomomi Nakamura et al. · Lung Cancer · 2011 · 64 citations

Oncogenic Agent, Medicine, Lung Adenocarcinoma Patients +7

Clinical benefits and complications of Dumon stent insertion for the treatment of severe central airway stenosis or airway fistula

Masahiro Mitsuoka, Tohru Sakuragi, Tsuyoshi Itoh · General Thoracic and Cardiovascular Surgery · 2007 · 48 citations

Dumon Stent Insertion, Interventional Pulmonology, Vascular Surgery +6

Modified Dumon stent for the treatment of a bronchopleural fistula after pneumonectomy

Kohsuke Tayama, Naofumi Eriguchi, Yasuhiko Futamata et al. · The Annals of Thoracic Surgery · 2003 · 46 citations · Full text

Interventional Pulmonology, Pneumothorax, Modified Dumon Stent +5